Intensity Therapeutics INTS
NASDAQ INTS
$3.42 -0.23 (-6.28%)
As of: Sep 29, 2026 · 3:55 PM EDT

Intensity Therapeutics (INTS) Interest Coverage Ratio (2022 - 2023)

Updated

Intensity Therapeutics' (INTS) Interest Coverage Ratio stood at -27.28 in FY2023, compared with -92.07 in FY2022.

Analysis

Intensity Therapeutics (INTS) Interest Coverage Ratio (2022 - 2023) Analysis & Trends

  • Per Business Quant data, INTS's Interest Coverage Ratio was -92.07 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.41
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 10.28
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 7.27
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 5.22
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -42.08
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Intensity Therapeutics 10.75 Mn 10.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -5.50
Mar 31, 2023 -15.11
Dec 31, 2022 -39.70
Sep 30, 2022 -116.90
Jun 30, 2022 -129.01
API Access

Intensity Therapeutics Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=INTS&period=max&api_key=YOUR_API_KEY